Показати скорочений опис матеріалу

dc.creatorOvsjanykova, Yu. O.
dc.creatorSytnik, K. M.
dc.creatorShemchuk, A. L.
dc.creatorZagayko, A. L.
dc.creatorFylymonenko, V. P.
dc.date2016-04-07
dc.date.accessioned2020-02-26T12:37:36Z
dc.date.available2020-02-26T12:37:36Z
dc.identifierhttps://ojs.tdmu.edu.ua/index.php/pharm-chas/article/view/6042
dc.identifier10.11603/2312-0967.2016.1.6042
dc.identifier.urihttps://repository.tdmu.edu.ua/handle/123456789/14961
dc.descriptionSYNTHESIS OF FUNCTIONAL DERIVATIVES OF 3-AMINO-2-R-7-(R'-PHENYL)-3H-THIENO[2,3-d]PYRIMIDINE-4-ONES AND STUDY OF THEIR ANTI-DIABETIC ACTIVITYOvsjanykova Yu.O., Sytnik K.M., Shemchuk L.A., Zagayko A.L., Fylymonenko V.P.National University of Pharmacy, KharkivIntroduction. Synthesis of 3-amino-2-R-7-(R'-phenyl)-3H-thieno[3,2-d] pyrimidine-4-ones was accomplished using interaction between 3-amino-4-(R-phenyl)-tiofen-2-carboxylic acids hydrazides with aliphatic carboxylic acids. The proposed reaction was proved itself as an efficient and convenient method for thienopyrimidine system constructing using available reagents under mild conditions, due to the fact that the obtained compounds contain primary amino group in the 3-d position. The main aim of this work was to study the reactivity of 3-amino-2-R-7-phenyl-3H-thieno[3,2-d]pyrimidine-4-one, to study possible chemical modification of the amino group in the 3-d position and to make an initial pharmacological screening of the obtained compounds.Investigation methods. The melting points were determined by capillary method. NMR spectra of synthesized compounds were recorded on the Varian Mercury VX-200, the operating frequency – 200MHz, solvent – DMSO-D6, internal standard – TMS. Elemental analysis was performed using analyzer Carbo Erba CHNS-O EA 1108.Diabetes was modeled by prolonged injection of low doses of dexamethasone. The experiment was performed on male Wistar rats, with 160-200 g weight. The blood serum was the studied object. Statistical data analysis was performed using the program STATISTICA (StatSoft Inc., USA, version 6.0). The significance of the intergroup differences was evaluated by nonparametric Mann-Whitney criterion.Results and discussion. The amides were obtained by treating the amines with corresponding chlorine anhydrides in dioxane medium. The interaction of the initial amine with methanesulfonyl chloride in dimethylformamide medium led to the formation of methansulfonamide. The interaction of amines with isocyanates or isothiocyanates led to corresponding ureas or thioureas formation. Heating the amine with 2,5-dimethoxytetrahydrofurane in glacial acetic acid medium for 2 hours leads to N-pyryl-derivative formation, that is proved by the appearance of characteristic pyryl methyn protons signals instead the amino group signal – triplet (β position) at 6.24 ppm and doublet (α position) at 7.08 ppm.According to recent literature data obtained thienopyrimidine compounds show the potential antidiabetic activity. Therefore we decided to study this type of activity. The examined synthetic compound, 3-amino-2-ethyl-7-(2-methoxy-phenyl)-3Н-thieno[2,3-d]pyrimidin-4-one, showed protective properties against diabetes. The high level of the studied activity can be attributed to the presence of methoxy group in the ortho position of the phenyl moiety and possible disturbance of the molecule planarity.Conclusions.1. Derivatives of 3-amino-2-R-7-(R'-phenyl)-3H-thieno[2,3-d] pyrimidine-4-one were synthesized by chemical modification of the amino group in the 3-d  position of the heterocycle. Conclusions concerning the amino group reactivity were formulated.2. The structure of the synthesized compounds was proved using Н1NMR spectroscopy, elemental analysis, and counter synthesis in some cases.3. Antidiabetic activity research (diabetes was caused by prolonged injection of low doses of dexamethasone) showed that the synthetic compound 3-amino-2-ethyl-7-(2-methoxy-phenyl)-3Н-thieno[2,3-d]pyrimidin-4-one reduced all studied indicators: level of blood glucose, insulin, lipids. Identified antidiabetic properties can be used to develop new medicines in order to correct the insulin resistance.References1. Prostoj metod sinteza 3-amino-2-R-7-(R'-fenil)-3H-tieno[2,3-d]pirimidin-4-onov / Ju.A. Ovsjanikova, K.M. Sytnik, V.P. Chernyh [i dr.] // Farmacija Kazahstana. – 2015. – № 5. – S. 39–45.2. Deeb Ali. Pyridazine derivatives and related compounds. part 11: 1synthesis of some pyrimido[4′,5′:4,5]thieno[2,3-c]pyridazines / Deeb Ali, Kotb Mahmoud, El-Abbasy Mohamed // Phosphorus, Sulfur and silicon and the related Elements. – 2004. – vol. 179; № 11. – P. 2245–2252.3. Bakhite Etify Abdel-Ghafar. Synthesis of New Pyrazolo[3,4-b]quinolines, Thieno[2,3-b]quinolines and Related Condensed Heterocyclic Systems / Bakhite Etify Abdel-Ghafar // Journal of the Chinese Chemical Society (Taipei, Taiwan)/ – 2001. – vol. 48; nb. 6B. – P. 1175 – 1184.4. Low-dose dexamethasone in the rat: a model to study insulin resistance / C. Severino, P. Brizzi, A. Solinas [et al.] // Am J Physiology – 2012. – vol. 283, № 2. – P. 367–373.5. Stroev E.A. Praktikum po biologicheskoj himii / E.A. Stroev, V.G. Makarova – M.: Vysshaja shkola, 1986. – 231 s.6. Putilina F.E. Opredelenie soderzhanija vosstanovlennogo glutationa v tkanjah / F.E. Putilina / Metody biohimicheskih issledovanij. Pod red. Prohorovoj M. I. – L.: Izd-vo Leningrad. un-ta, 1982. – S. 183–185.7. Mashkovskyj M.D. Lekarstvennie sredstva. – Novaja Volna: Umerenkov, 2007. – 1206 s.8. Copper-Catalyzed Coupling Reaction of 2-Thioxo-4-quinazolinone and Thieno[3,2-d]pyrimidin-4-one Methane Sulfonamide with Aryl Iodides: Preparation of Potential COX-2 Selective Inhibitors / Perdicaro Antonio, Granata Giuseppe, Marrazzo Agostino [et al.] // Synthetic Communications. – 2008. – vol. 38; nb. 5. – P. 723 – 737.9. Abdull Mohamed M. Anti-inflammatory activity of heterocyclic systems using abietic acid as starting material / Abdull Mohamed M. // Monatshefte fur Chemie. – 2008. – vol. 139; nb. 6. – P. 697–705.10. Amr Abd El-Galil E. Synthesis, Reactions, and Anti-inflammatory Activity of Heterocyclic Systems Fused to a Thiophene Moiety Using Citrazinic Acid As Synthon / Amr Abd El-Galil E., Sabry Nermien M., Abdulla Mohamed M. // Monatshefte fur Chemie. – 2007. – vol. 138; nb. 7. – P. 699–707.11. Synthesis of some pyrimido[4′,5′:4,5]thieno[2,3-b]quinolines and related heterocycles / Hafez A.A. Abdel, El-Dean A. Kamal, Hassan A.A. [et al.] // Journal of Heterocyclic Chemistry. – 1996. – vol. 33; nb. 2. – P. 431–438.12. Ho Yuh-Wen. Synthesis of Some New Pyrido[3′,2′:4,5]thieno[3,2-d]pyrimidin-4(3H)-ones and Pyrido[3′,2′: 4,5]thieno[2,3-e]-1,2,4-triazolo[1,5-c]pyrimidine Derivatives / Ho Yuh-Wen // Journal of the Chinese Chemical Society (Taipei, Taiwan). – 2001. – vol. 48; nb. 6B. – p. 1163–1174.13. Synthesis and reactivity of 3-amino-9-methoxymethyl-7-methyl-3,4-dihydropyrido-[3′,2′:4,5]thieno[3,2-d]pyrimidin-4-ones / E.S. Kostenko, M.M. Lipunov, E.A. Kaigorodova [et al.] // Chemistry of Heterocyclic Compounds (New York, United States). – 2007. – vol. 43; nb. 11. – P. 1466–1476.14. El-Telbany Farag. Synthesis of a novel series of 3-substituted [1]benzothieno[3,2-d]pyrimidine derivatives / El-Telbany Farag, Robert O. Hutchins // Journal of Heterocyclic Chemistry – 1985. – vol. 22; nb. 2. – P. 401–403.15. Discovery of diethyl 2,5-diaminothiophene-3,4-dicarboxylate derivatives as potent anticancer and antimicrobial agents and screening of anti-diabetic activity: Synthesis and in vitro biological evaluation. Part 1 / Khurshed Bozorov, Hai-Rong Ma, Jiang-Yu Zhao [et al.] // European Journal of Medicinal Chemistry. – 2014. – vol. 84, nb. 12. – P. 739–745.16. The highly potent and selective dipeptidyl peptidase IV inhibitors bearing a thienopyrimidine scaffold effectively treat type 2 diabetes / Jifeng Deng, Li Peng, Guicheng Zhang [et al.] // European Journal of Medicinal Chemistry. – 2011. – vol. 46, Issue 1. – P. 71–76.17. Buren J. Dexamethasone decreases GLUT 1 and GLUT 4 content in primary cultured rat adipocytes / J. Buren, J. Ereksson // Diabetol – 1999. – vol. 42, № 1. – P. 170.18. Vavilova L.L. Modeljuvannja insulinorezystentnosti ta kompleksu suputnih metabolichnyh porushen' za dopomogoju deksametazonu / L. L. Vavilova, T. A. Krjachok, T. V. Talajeva // Fiziologichnyi zhurnal. – 2009. – T. 55, № 3. – S. 75–80.19. Modulation of adipose tissue development by pharmacological inhibition of PAI-1 / D. L. Grandall, E. M. Quinet, S. El Ayachi [et al.] // Arterioscler Thromb Vascular Biol. – 2006. – № 26. – P. 2209–2218.20. Zagajko A. L. Metabolіchnij sindrom: mehanіzmi rozvitku ta perspektivy antioksidantnoi terapii: Monografіja / A. L. Zagajko, L. M. Voronіna, K. V. Strel'chenko. – H.: Vid-vo NfaU: Zolotі storіnki, 2007. – 216 s.21. Glucocorticoids and tumor necrosis factor increase oxidative stress and suppress wnt protein signaling in osteoblasts / M. Almeida, L. Han, E. Ambrogini [et al.] // The J Biol Chem – 2011. – vol. 286, № 52. – P. 44326–44335.uk-UA
dc.formatapplication/pdf
dc.languageukr
dc.publisherТернопільський державний медичний університет імені І. Я. Горбачевського МОЗ Україниuk-UA
dc.relationhttps://ojs.tdmu.edu.ua/index.php/pharm-chas/article/view/6042/5536
dc.rightsАвторське право (c) 2016 Фармацевтичний часописuk-UA
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0uk-UA
dc.sourcePharmaceutical Review; No. 1 (2016); 9-18en-US
dc.sourceФармацевтичний часопис; № 1 (2016); 9-18uk-UA
dc.source2414-9926
dc.source2312-0967
dc.source10.11603/2312-0967.2016.1
dc.titleSYNTHESIS OF FUNCTIONAL DERIVATIVES OF 3-AMINO-2-R-7-(R'-PHENYL)-3H-THIENO[2,3-d]PYRIMIDINE-4-ONES AND STUDY OF THEIR ANTI-DIABETIC ACTIVITYuk-UA
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion


Долучені файли

ФайлРозмірФорматПереглянути

Даний матеріал не має долучених файлів.

Даний матеріал зустрічається у наступних фондах

Показати скорочений опис матеріалу